Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins
- PMID: 17931161
- PMCID: PMC2849181
- DOI: 10.1586/14760584.6.5.821
Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins
Abstract
The heat-labile enterotoxins expressed by Vibrio cholerae (cholera toxin) and Escherichia coli (LT-I, LT-IIa and LT-IIb) are potent systemic and mucosal adjuvants. Coadministration of the enterotoxins with a foreign antigen produces an augmented immune response to that antigen. Although each enterotoxin has potent adjuvant properties, the means by which the enterotoxins induce various immune responses are distinctive for each adjuvant. Various mutants have been engineered to dissect the functions of the enterotoxins required for their adjuvanticity. The capacity to strongly bind to one or more specific ganglioside receptors appears to drive the distinctive immunomodulatory properties associated with each enterotoxin. Mutant enterotoxins with ablated or altered ganglioside-binding affinities have been employed to investigate the role of gangliosides in enterotoxin-dependent immunomodulation.
Figures
Similar articles
-
Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.Infect Immun. 2007 Feb;75(2):621-33. doi: 10.1128/IAI.01009-06. Epub 2006 Nov 21. Infect Immun. 2007. PMID: 17118982 Free PMC article.
-
Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.Infect Immun. 2005 Mar;73(3):1330-42. doi: 10.1128/IAI.73.3.1330-1342.2005. Infect Immun. 2005. PMID: 15731030 Free PMC article.
-
Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).Clin Vaccine Immunol. 2010 Jun;17(6):969-78. doi: 10.1128/CVI.00076-10. Epub 2010 Apr 14. Clin Vaccine Immunol. 2010. PMID: 20392887 Free PMC article.
-
The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.Immunol Cell Biol. 1998 Jun;76(3):270-9. doi: 10.1046/j.1440-1711.1998.00745.x. Immunol Cell Biol. 1998. PMID: 9682971 Review.
-
Cholera-like enterotoxins and Regulatory T cells.Toxins (Basel). 2010 Jul;2(7):1774-95. doi: 10.3390/toxins2071774. Epub 2010 Jul 6. Toxins (Basel). 2010. PMID: 22069660 Free PMC article. Review.
Cited by
-
Recent progress in mucosal vaccine development: potential and limitations.Nat Rev Immunol. 2012 Jul 25;12(8):592-605. doi: 10.1038/nri3251. Nat Rev Immunol. 2012. PMID: 22828912 Review.
-
Enhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2.Vaccine. 2010 May 7;28(21):3696-705. doi: 10.1016/j.vaccine.2010.03.016. Epub 2010 Mar 21. Vaccine. 2010. PMID: 20332049 Free PMC article.
-
LT-K63 Enhances B Cell Activation and Survival Factors in Neonatal Mice That Translates Into Long-Lived Humoral Immunity.Front Immunol. 2020 Oct 23;11:527310. doi: 10.3389/fimmu.2020.527310. eCollection 2020. Front Immunol. 2020. PMID: 33193301 Free PMC article.
-
Transcutaneous antigen delivery system.BMB Rep. 2013 Jan;46(1):17-24. doi: 10.5483/bmbrep.2013.46.1.001. BMB Rep. 2013. PMID: 23351379 Free PMC article. Review.
-
Sialoglycan-binding patterns of bacterial AB5 toxin B subunits correlate with host range and toxicity, indicating evolution independent of A subunits.J Biol Chem. 2022 May;298(5):101900. doi: 10.1016/j.jbc.2022.101900. Epub 2022 Apr 7. J Biol Chem. 2022. PMID: 35398357 Free PMC article.
References
-
- Hajishengallis G, Arce S, Gockel CM, Connell TD, Russell MW. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections. Journal of Dental Research. 2005;84(12):1104–1116. - PubMed
-
- Cheng E, Cardenas-Freytag L, Clements JD. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT) Vaccine. 1999;18(12):38–49. - PubMed
-
- McCluskie MJ, Weeratna RD, Clements JD, Davis HL. Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants. Vaccine. 2001;19(27):3759–3768. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources